pandemic healthy in are you the [Elisa]. our company and a these and discussed conference challenging due am our retail be the and that have to hope XXXX proved industry, responded earnings us headwinds COVID-XX. your for and families customers, on and impact for calls. The you, we times. extended provide significant circumstances, intensified joining of staying predominantly Thank to you to today's afternoon, pressures previous under regulatory service thank the how uncertainty very our customers. uninterrupted adapting Good I for year-long COVID-XX and of competitive safe We difficult proud such quickly call. year our company continuing for challenging created to
CV third including of during to due COVID-XX, CV the We long-term Sciences, daily Acute our CV in are Consumer products, X the sustainable a primary products privileged products Defense team reflecting employees products demand to the competitive upon past of immunity Innovation health quarter. awareness first new provide for these long-term in will value for XXXX quality to growth. the that platform strong several deliver heightened immunity creating and our and and corporate focus: dedicated wellness. year, mission daily and and surged areas have of and strategy. introduced advantages our a committed of underscoring We for remain
science-based much-loved a available the line through practitioners. grew family quarter, wide formulated XX% pet CBD XXXX, $X.X days, double-digit natural, address our market, immunity an by is plant-based opportunity The and of market enables we that for at products post-marketing exclusively for we per medicines. introduced pet in estimated is on growth alone, these This approximately product rapidly projected clinical natural for alternatives in only as through of alternative CBD annually CV supported Sciences. of to members. owners cats. a $X clinical is is which future ProCBD at in is studies we This are randomized dogs growing turned full last full launched a hem consumers to market the in line PlusCBD high-strength very the in compelling extracts XXXX, XX% ProCBD, and America Pet, increase exclusively good strong published line In practitioners strength In health us estimated products also line to at year rates. product product the interest to annually review. behind billion the increasingly drive XX and controlled a We investigations, billion the by to market are ailments encouraged in safety science reaching the growing and and range North by position and believe over target fourth
distribution refreshed our and X,XXX carrying products. the us expand the ended We significantly products in packaging year New retail stores our helped XXXX. over breadth of with
a strategy, the FDM significant channel our store QX, as fourth sharp net came quarter. from the the for our of our XXXX. additions of in acceleration position entered Importantly, the A portion to Consistent we strengthening we with to majority soon account distribution store on our convenience quarter line announcement progress And expansion with on third into the continue value the of channel in channel. our the c-store lane. introduction store growth anticipate make We XXXX. expansion product during happy continued
core channel strategy, our forward. continued growth a direct-to-consumer going and element including during XXXX of Our our remains investments
including competitive position a pressures, competitors We thousands by of mitigating also barrier impact capabilities environment. been out in entry strengthen building regulatory our while have to under-defined digital low to new the very of external our
traffic from what and in programs a product Sales accounted channel The that for is and profitable DTC managing in customer investments during channel our understanding new ship up with resulted behavior, the costs. result development. well development in revenue website stronger Our acquisition XX% of is relationship of the fourth have of while XX% our total positioned for continued quarter quarter, affiliate DTC purchase triggers closer gaining net having XXXX while insight a auto customers, fourth valuable in our XXXX. effectively for SEO growth and
To we the in our on development sales. brand For XX-plus and full great be partners we our developing efforts across this customers. XXXX, of products the refresh brands XX% SKUs XX% represented have and X and these received at nearly PlusCBD-branded and to DTC front XXXX, or product to from flagship product XXXX. the summarize year compared packaging sales refreshed market marketing feedback total under sales channel of effectively we distribution industry. We us multiple efforts category launched And believe position new new and during
On the diverse enforcement. front, work group to with are Washington, that continue stakeholders oversight a regulatory regulation, we advocating CBD D.C. and for of
standards of staff Sciences' in product consumers. improve Standards laboratories. protects the working industry and transparency CV the testing National Cannabis Technologies accuracy of example, and For robust laboratory Assurance and program cannabis Institute Quality been Having the on and capability have with to supports methods
in for framework we goes credible eliminating most We of Monday look is hemp allowing that dietary a This U.S. have in channels, by Congress see will economic and in hemp that reminder it of consumers surge This quickly a rule growth legal like and and hemp Program farmers. farmers Final confident framework yet has CBD Sciences have month, H.R.XXX, young hemp support provide which sales opportunities must United and act In the what occur to Rule, remain effect which that States for the unregulated the clear FDA is reintroduced a provides hemp a Agriculture FDA the to which published regulatory effectively. Consumer all regulatory D.C. protects XXXX, and the U.S. Act expected good a availability made farming to we the clarity will to of addition, CBD the only of successfully CBD like. into way consumer be companies for CV the energized open Hemp industry CBD regulatory across mature Protection To hemp-derived Market businesses conversation establish Department regulated demand significant and CBD, supplements the industry the compete Stabilization enforcement and products. U.S. catalyst to and trustworthy Production that has Domestic this of how and
Now I move to will our drug development program. on
discussed that from previous XX, our December granted our patent issuance of received Also, on notification calls, in drug we the was notice As XXXX. the Japanese received earnings market. the May for Japanese on patent XXXX, we in patent office USPTO from formal
success, validation We strong are patent U.S. grants, Japan prosecution major as And by our program. patent world our markets. our provides evidenced and for continuing the in
our completed Phase studies I toxicological study. support in our and planned of have clinical pharmacological We
through a guidance We have global do impacted logistics a date work operations and COVID-XX. continue to result, I for not we by clinical commencing Phase And a as yet. trial,
this looking in very that at smokeless $X is an program effective market. due few continue worldwide However, success our billion. therapeutic forward, are we options improvement starting We and addiction. options the we as to see forward. impacted effective, believe we for program partnering. that global are Conservative are treatment move are strongly this We big to drug of including know the a to developing move to estimates treatment this at all of development potential start operations COVID-XX program tobacco There in
to Before turn and over We generally. it in the reiterate the development, want environment to Joerg, with have industry. goal to expansion colleagues. our our cannabis to regulatory industry I will continued and confidence CBD, advance believe partners Congress the and our the I of with Congress and administration of current opportunity industry a responsibly continue we work and big that And members on
companies and and like current that will and pandemic, at sustainable will the resolve. We be environment the are the regulatory uncertainty confident trusted Sciences CV the environment normalized will of and and competitive market. more most growing including evolve this respected the COVID-XX headwinds, A forefront thrive competitive
Joerg turn it to run let financials. our to me over Now, through